BRIEF published on 07/08/2025 at 18:35, 4 months 27 days ago NEOVACS: Update of share capital and voting rights Voting Rights Actions Funding Investments Émission
BRIEF published on 07/03/2025 at 21:05, 5 months 1 day ago Neovacs issues €0.4 million in bonds Shareholders Bond Issue Dilutive Financing Equitization Trust Management
BRIEF published on 07/01/2025 at 08:05, 5 months 3 days ago Neovacs seeks investors for Arnity Therapeutics Investment Biotechnologies Néovacs Asthma Arnity Therapeutics
BRIEF published on 06/03/2025 at 18:35, 6 months 1 day ago NEOVACS: Update on voting rights and share capital Voting Rights Actions OCEANE Dilutive Financing Néovacs
BRIEF published on 06/02/2025 at 08:05, 6 months 2 days ago Neovacs Share Consolidation: Key Information Euronext Growth Dilution Suspension Consolidation Of Shares Néovacs
BRIEF published on 05/27/2025 at 21:05, 6 months 8 days ago NEOVACS raises 0.5 million euros to finance its research projects Biotechnology Fundraising Dilution OCEANE-BSA Kinoid® Research
BRIEF published on 05/16/2025 at 18:35, 6 months 19 days ago NEOVACS: Update on the number of shares and voting rights Voting Rights Actions Investment OCEANE Issue Of Shares
BRIEF published on 05/06/2025 at 20:05, 6 months 29 days ago Capital reduction at Neovacs Capital Reduction Investor Caution Dilutive Financing Nominal Value Stock Market Pressure
BRIEF published on 05/06/2025 at 08:05, 6 months 29 days ago Neovacs: 2024 Annual Results and Outlook Financial Results Funding MRNA Vaccine Pharnext Néovacs
BRIEF published on 05/05/2025 at 12:05, 6 months 30 days ago Neovacs raises 1.2 million euros in fundraising Biotechnology Fundraising Investment Dilution OCEANE-BSA
Published on 12/05/2025 at 02:35, 2 hours 50 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 25 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 20 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 25 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 55 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 34 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 10 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 15 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 25 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 40 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 41 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 24 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
